Page last updated: 2024-12-10

2-(4-aminophenoxy)isophthalonitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-(4-aminophenoxy)isophthalonitrile, also known as 2-[(4-aminophenyl)oxy]-1,3-dicyanobenzene, is an organic compound with the molecular formula C14H9N3O. It is a white to yellowish solid that is sparingly soluble in water.

**Structure and Properties:**

* **Structure:** The molecule consists of an isophthalonitrile core (benzene ring with two nitrile groups) attached to a 4-aminophenoxy group.
* **Melting Point:** 172-174 °C
* **Solubility:** Sparingly soluble in water, soluble in organic solvents like ethanol and acetone.

**Importance in Research:**

2-(4-aminophenoxy)isophthalonitrile is an interesting compound for research due to its potential applications in various fields:

* **Organic Electronics:** The presence of both electron-donating (amino group) and electron-withdrawing (nitrile groups) moieties makes it a promising candidate for the development of organic semiconductors and photovoltaics. Its ability to form thin films and exhibit electrical conductivity has been explored.
* **Materials Science:** It can be used as a building block for the synthesis of various functional polymers and supramolecular architectures. Its rigid structure and strong intermolecular interactions could lead to materials with unique optical and mechanical properties.
* **Drug Discovery:** The compound exhibits certain biological activities, such as anti-inflammatory and antioxidant properties. Further research is needed to explore its potential as a drug candidate or lead compound.
* **Analytical Chemistry:** Its fluorescence properties make it potentially useful as a fluorescent probe or sensor for the detection of specific analytes.

**Key Advantages:**

* **Versatile Synthesis:** The molecule can be synthesized using relatively straightforward and well-established organic chemistry techniques.
* **Functional Group Variety:** The presence of different functional groups (amino, nitrile, ether) allows for further modifications and functionalization.
* **Potential for Tunable Properties:** By altering the substituents on the benzene ring or introducing different functionalities, the electronic and optical properties of the compound can be tuned.

**Research Directions:**

* Investigating its use in organic field-effect transistors (OFETs) and organic solar cells.
* Exploring its potential for the development of new materials with improved optical properties or enhanced mechanical strength.
* Evaluating its biological activity and potential as a drug candidate.
* Developing new applications based on its fluorescence properties, such as sensing and imaging.

**In summary, 2-(4-aminophenoxy)isophthalonitrile is a versatile and promising molecule with potential applications in various research areas, including organic electronics, materials science, drug discovery, and analytical chemistry. Its unique structure, functional group diversity, and tunable properties make it a valuable compound for further exploration and development.**

Cross-References

ID SourceID
PubMed CID2805873
CHEMBL ID1370803
CHEBI ID183419

Synonyms (14)

Synonym
IDI1_012455
OPREA1_662427
2-(4-aminophenoxy)isophthalonitrile
MLS000851338
smr000457781
MAYBRIDGE3_001068
SR-01000643596-1
HMS1434A12
CHEBI:183419
2-(4-aminophenoxy)benzene-1,3-dicarbonitrile
CCG-54504
HMS2788P05
CHEMBL1370803
BRD-K44909225-001-07-9
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glp-1 receptor, partialHomo sapiens (human)Potency3.16230.01846.806014.1254AID624417
chromobox protein homolog 1Homo sapiens (human)Potency100.00000.006026.168889.1251AID540317
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's2 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.17 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]